Loyens & Loeff acted as Dutch corporate counsel to the underwriters with respect to the IPO of InflaRx N.V. on the NASDAQ Global Select Market, under…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
